China, Aug. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'An assessment of the human biodistribution and radiation dosimetry of the radionuclide-labeled IR199 in patients with gastric cancer and pancreatic cancer'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600129744

Registration Time: 2026/08/10

Type: Interventional study

Primary Sponsor: Huashan Hospital, Fudan University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=336649

Published by HT Digital Content Services with permission from Health Daily Digest....